Director/PDMR Shareholding

Smith & Nephew Plc

30 May 2024

 

SMITH & NEPHEW PLC

30 May 2024

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

On 29 May 2024, Smith & Nephew plc (the "Company") received notification of the following transactions as detailed below.

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc SPON ADR American Depositary Shares (ADS)
Identification code	ISIN: US83175M2052
Nature of the transaction	Director and PDMRs are participants of the Company's Employee Stock Purchase Plan, which purchased American Depository Shares through the Company's Dividend Re-Investment Plan following the 2023 final dividend payment on 22 May 2024.
Date of Transaction	2024-05-24
Place of Transaction	New York Stock Exchange

Name	Director / PDMR	Price ($)	Volume	Aggregated information
Craig Gaffin (President, Global Orthopaedics)	PDMR	24.9026	24.14366	N/A Single Transaction
Mizanu Kebede (Chief Quality & Regulatory Affairs Officer)	PDMR	24.9026	18.50369	N/A Single Transaction
Deepak Nath (Chief Executive Officer)	Director	24.9026	24.14366	N/A Single Transaction
Paul Connolly (President, Global Operations)	PDMR	24.9026	18.16357	N/A Single Transaction
Scott Schaffner (President, Sports Medicine)	PDMR	24.9026	44.13636	N/A Single Transaction

Sarah Carne  

Deputy Company Secretary

Smith & Nephew plc

Tel:  [phone]

 

END